← Back to Patent Explorer
US3624209A Expired / Lapsed US ⏱️ 0.0 years remaining

Composition for treatment of gastro-intestinal disorders

Assignee: Bristol Myers Co
•
Filing: 1966-12-28
•
Granted: 1971-11-30
•
Expires: 1986-12-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A pharmaceutical composition useful for the treatment of gastrointestinal disorders comprising a diethylaminoethyl cross-linked dextran anion exchanger and a pharmaceutical carrier or another therapeutic agent and a method of treating gastro-intestinal disorders in mammals by the oral administration of such a composition.

Inventors

  • 👤 Edmund S Granatek
  • 👤 Alphonse P Granatek

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-22 23:01
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/74; A61K31/785; A61K33/00; A61K33/06; A61K33/08; A61K33/10

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 18 words
A pharmaceutical composition for treatment of gastro-intestinal disorders according to claim 1, wherein said antacid is aluminum hydroxide.
Claim 2
Dependent Claim 18 words
A pharmaceutical composition for treatment of gastro-intestinal disorders according to claim 1, wherein said antacid is magnesium hydroxide.
Claim 3
Dependent Claim 18 words
The pharmaceutical composition for treatment of gastro-intestinal disorders of claim 1 in unit dosage form for oral administration.
Claim 4
Dependent Claim 19 words
The pharmaceutical composition for treatment of gastro-intestinal disorders of claim 1 in the form of a dosage unit tablet.
Claim 5
Independent Claim 42 words
The method of treating gastro-intestinal ulcers in mammals which comprises orally administering an effective amount of a composition comprising diethylaminoethyl cross-linked dextran anion exchanger and an antacid selected from the group consisting of aluminum hydroxide, magnesium hydroxide, aluminum glycinate and calcium carbonate.
Claim 6
Dependent Claim 11 words
The method of claim 6 wherein said antacid is aluminum hydroxide.

References Cited (Backward Citations)

US2554072A Cited
US2581035A Cited
US3002823A Cited
US3042667A Cited
US3107203A Cited
US3364111A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1974-11-29 1975-05-31 1975-11-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1978-11-29 1979-05-31 1979-11-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1982-11-29 1983-05-31 1983-11-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag